Compositions and methods for treating eye disorders
By using muscarinic agonist and brimonidine composition, combined with nonionic surfactants and adhesives, the side effects problems in presbyopia treatment are solved, and the myopia acuity and focus ability of presbyopia patients are improved for a long time, reducing the ability of presbyopia patients side effects occur.
CN118922190APending Publication Date: 2024-11-08LENZ THERAPEUTICS OPERATIONS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- CN202280090563.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2021-12-16
- Filing Date
- 2022-12-15
- Publication Date
- 2024-11-08
Smart Images

Figure CN118922190A_ABST
Abstract
The present invention is directed to compositions and methods for treating presbyopia, irregular astigmatism, and / or ametropia comprising from about 0.1% to about 4.0% w / v of a muscarinic agonist and from about 0.07% to about 0.15% w / v of brimonidine.
Need to check novelty before this filing date? Find Prior Art
